Back To Schedule
Monday, June 28 • 12:30pm - 1:00pm
#108 IT: Deloitte (ConvergeHEALTH) Innovation Theater: Automating Adverse Event Case Processing Through Machine Learning and Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate

Adverse Event (AE) collection, assessment and reporting is a foundational activity of Sanofi’s pharmacovigilance and license to operate. With 600K+ AE cases expected annually, it is an intensive, manual, expensive, and time-consuming activity. Hear about Sanofi’s success with case processing automation via natural language processing, machine learning and artificial intelligence with Deloitte’s ConvergeHEALTH Safety Cognitive Platform. And the benefits of using cloud-based automation technology.



avatar for Amanda Kirby Bowles

Amanda Kirby Bowles

Managing Director, Deloitte, United States
Amanda Bowles has over 14 years of life sciences experience including over 10 years specializing as a pharmacovigilance and drug safety systems subject matter advisor. Amanda has in depth experience in drug safety, pharmacovigilance and regulatory affairs, including extensive experience... Read More →
avatar for Glenn Carroll

Glenn Carroll

Principal, Deloitte, United States
Glenn Carroll is a principal in our life science strategy practice with over 15 years pharmaceutical and biotech experience. Glenn leads Deloitte's US Safety and Medical practices. He has a strong track record in delivering strategic and operational excellence, specifically in the... Read More →
avatar for Deloitte


United States
avatar for Stephen Kuske

Stephen Kuske

Global Pharmacovigilance Operations Head, Sanofi, United States
avatar for Anand Ramanathan

Anand Ramanathan

Global Pharmacovigilance ITS Head, Sanofi, United States

Monday June 28, 2021 12:30pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044